Stocks
GlaxoSmithKline (GSK) FCF US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| FCF, £ | ? | 5 145 000 000 | 5 145 000 000 | 5 145 000 000 | 4 004 000 000 | 4 004 000 000 | 3 440 000 000 | ||
| Changes by years, y/y, % | +2% | 0% | 0% | -22% | 0% | -9.6% | |||
GlaxoSmithKline. FCF, £
GlaxoSmithKline. FCF, changes, %
GlaxoSmithKline. FCF, sum by quarters, £
GlaxoSmithKline (GSK) FCF US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| FCF, £ | ? | 376 000 000 | 440 000 000 | 440 000 000 | 1 312 000 000 | 1 312 000 000 | 3 440 000 000 | |
| Changes by years, y/y, % | -179% | -43% | -43% | -23% | -23% | |||
| Changes by quarters, q/q, % | -83% | +17% | 0% | +198% | 0% | |||
